<qa>  What is the resection rate for subjects with borderline resectable or lymph noI. To determine the R0 complete resection resection rate for subjects with borderline resectable or lymph node positive pancreatic adenocarcinoma treated with a multimodality neoadjuvant therapy of preoperative gemcitabine gemcitabine hydrochloride and ABRAXANE nab-paclitaxel followed by 5-fluorouracil fluorouracil based image-guided intensity-modulated radiation therapy IG-IMRT chemoradiotherapy. 